Tuesday, October 28, 2025
- 10:30AM-12:30PM
-
Abstract Number: 1942
An Agnostic Evaluation of Serum Proteins Discriminates the Severity of Ultrasound Arthritis in SLE Patients
(1936–1971) Imaging of Rheumatic Diseases Poster- 10:30AM-12:30PM
-
Abstract Number: 2564
An illustration-based patient-reported outcome measure reveals concealed symptoms in patients with rheumatoid arthritis and the factor contributing to the discrepancy between patient and evaluator global assessments
(2547–2566) ARP Posters I- 10:30AM-12:30PM
-
Abstract Number: 2162
An Updated Needs Assessment for the Virtual Rheumatology Program for Fellows in Training (V-FIT)
(2159–2194) Professional Education Poster- 10:30AM-12:30PM
-
Abstract Number: 2242
Analysis of Bronchoalveolar Fluid Cytokine Profile as a Way to Understand the Lung Disease Associated with Systemic Juvenile Idiopathic Arthritis
(2227–2264) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2395
Analysis of histopathological changes in the placenta of patients with systemic lupus erythematosus
(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 1934
Analysis of the Determinants of Vaccine Acceptance and Hesitancy in Germany: A Mixed-Methods Approach Incorporating Health Insurance Data and Qualitative Interviews with Patients and Physicians
(1914–1935) Health Services Research Poster III- 10:30AM-12:30PM
-
Abstract Number: 2397
Analytical Performance of a Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases in a Reference Laboratory in Southern France
(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2398
Analytical performance of the HEp-2 substrate Diagnostic Kit for ANA as an initial step in the evaluation of a novel Fully Automated IFA Analyzer in a laboratory in England
(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2120
Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-Scale Observational Study
(2106–2123) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: LB04
Anti-CD20/BCMA Bispecific CAR-T Cell Therapy Promotes Immune Reset and Sustained Drug Free Remission in Refractory Autoimmune Diseases
(LB01–LB18) Late-Breaking Posters- 10:30AM-12:30PM
-
Abstract Number: 2417
Anti-dense fine speckled 70 antibodies in undefined disease, systemic autoimmune rheumatic diseases and controls
(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2386
Anti-Trim72 Auto-antibodies In Systemic Lupus Erythematosus Patients and a Lupus Mouse Model with Myocarditis Compromise Membrane Repair in Mouse & Human Cardiomyocytes
(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 1858
Antinuclear Antibodies from Systemic Sclerosis Patients Enter Cells via a Clathrin Endocytosis Mechanism and Interact with their Intracellular Antigen.
(1855–1876) Systemic Sclerosis & Related Disorders – Basic Science Poster II